Virtu Financial LLC Concert Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$2.8 - $6.36 $144,169 - $327,470	51,489 Added 369.71%	65,416 $275,000
Q1 2022 May 17, 2022	BUY	$2.73 - $3.94 $38,020 - $54,872	13,927 New	13,927 $47,000
Q4 2019 Feb 04, 2020	SELL	$5.71 - $9.22 $66,932 - $108,076	-11,722 Closed	0 $0
Q3 2019 Nov 20, 2019	BUY	$5.88 - $12.35 $68,925 - $144,766	11,722 New	11,722 $69,000
Q2 2019 Aug 13, 2019	SELL	$9.44 - $13.12 $111,760 - $155,327	-11,839 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$12.07 - $17.54 $142,896 - $207,656	11,839 New	11,839 $143,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.